JAGX
JAGX
NASDAQ · Pharmaceuticals

Jaguar Health Inc

$0.97
+0.03 (+3.11%)
As of Aug 8, 2:37 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +4,845.3% upside
Low Target $35.39
Average Target $47.90
High Target $54.68
Current Price $0.97
Current
$0.97
Target
$47.90
$35.39 $47.90 avg $54.68
Scenario Analysis
Bear Case
$35.39
3,553.7%
Low target
Base Case
$47.90
+4,845.3%
Avg target
Bull Case
$54.68
+5,545.3%
High target
Risk/Reward
1.6x
Balanced
Price in Context
Target vs 52W High
$47.90
-48.4% vs high
Next Earnings Report
Aug 12, 2026
3d
until earnings
EPS Est: $-1.52
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%